Barclays »

Tempest Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Tempest Therapeutics (TPST) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Tempest Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tempest Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tempest Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $245 222 1.11

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Tempest Therapeutics

Sabby Management
Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
BlackRock
Squarepoint Ops
Northern Trust
Citadel Advisors
UBS Group
Tower Research Capital
Morgan Stanley
Advisor Group Holdings
Federation des caisses Desjardins du Quebec
Jones Financial Companies, L.L
Barclays

View all funds holding Tempest Therapeutics